Skip to main content
SpringerLink
Log in

Pathology of Mesenchymal Lesions of GI Tract

  • Chapter
  • First Online:
Surgical Pathology of the Gastrointestinal System

  • 1748 Accesses

Abstract

The chapter gives an overview of different mesenchymal lesions occurring in the gastrointestinal tract. After going through this chapter, the reader would be competent enough for the following things:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumours: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol. 2007;23:149–58.

    PubMed  Google Scholar 

  2. Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumour (GIST): facts, speculations, and myths. J Cell Mol Med. 2006;10:995–1013.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983;7:507–9.

    CAS  PubMed  Google Scholar 

  4. Schaldenbrand JD, Appelman HD. Solitary solid stromal gastrointestinal tumors in von Recklinghausen’s disease with minimal smooth muscle differentiation. Hum Pathol. 1984;15:229–32.

    CAS  PubMed  Google Scholar 

  5. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988;335:88–9.

    CAS  PubMed  Google Scholar 

  6. Huizinga JD, Thuneberg L, Klüppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature. 1995;373:347–9.

    CAS  PubMed  Google Scholar 

  7. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol. 1993;17:887–97.

    CAS  PubMed  Google Scholar 

  8. Miettinen M, Virolainen M, Maarit-Sarlomo R. Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol. 1995;19:207–16.

    CAS  PubMed  Google Scholar 

  9. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–80.

    CAS  PubMed  Google Scholar 

  10. Nilsson B, Bumming P, Meis-Kindblom JM, Malysz J, Mikkelsen HB, Bernstein A. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era: a population-based study in western Sweden. Cancer. 2005;103:821–9.

    PubMed  Google Scholar 

  11. Sandvik OM, Soreide K, Kvaloy JT, Gudlaugsson E, Søreide JA. Epidemiology of gastrointestinal stromal tumors: single-institution experience and clinical presentation over three decades. Cancer Epidemiol. 2011;35:515–20.

    PubMed  Google Scholar 

  12. Cho MY, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, et al. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci. 2010;25:853–62.

    PubMed  PubMed Central  Google Scholar 

  13. Terada T. Gastrointestinal stromal tumor of the digestive organs: a histopathologic study of 31 cases in a single Japanese institute. Int J Clin Exp Pathol. 2010;3:162–8.

    CAS  Google Scholar 

  14. Rauf F, Burgiri Y, Pervez S. Gastrointestinal stromal tumors: a demographic, morphological and immunohistochemical study. Indian J Gastroentrol. 2007;26:214–6.

    CAS  Google Scholar 

  15. Rajappa S, Muppavarapu KM, Uppin S, Digumarti R. Gastrointestinal stromal tumors: a single institution experience of fifty cases. Indian J Gastroentrol. 2007;26:225–9.

    Google Scholar 

  16. Lakshmi VA, Chacko RT, Kurien S. Gastrointestinal stromal tumors: a 7 year experience from a tertiary hospital. Indian J Pathol Microbiol. 2010;53:628–33.

    PubMed  Google Scholar 

  17. Attili SV, Arsnanda BB, Mandapal T, Anjaneyulu V, Sinha S, Reddy OC. Factors influencing progression-free survival in gastrointestinal stromal tumors with special reference to pathologic features, cytogenetics, and radiologic response. Gastrointest Cancer Res. 2011;4:173–7.

    PubMed  PubMed Central  Google Scholar 

  18. Ravikumar G, Kalegowda IY, Ananthamurthy A. Clinicopathological spectrum of gastrointestinal stromal tumors – experience at a tertiary care centre. Ind J Cancer. 2011;48:466–70.

    CAS  Google Scholar 

  19. Vij M, Agrawal V, Kumar A, Pandey R. Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases. Indian J Gastroenterol. 2010;29:231–6.

    PubMed  Google Scholar 

  20. Kumari N, Priyaa V, Shukla P, Kumar A, Aggarwal R, Krishnani N. Gastrointestinal stromal tumor: genotype frequency and prognostic relevance. Appl Immunohistochem Mol Morphol. 2018;26:153–60.

    PubMed  Google Scholar 

  21. Foo WC, Liegl-Atzwanger B, Lazar AJ. Pathology of gastrointestinal stromal tumors clinical medicine insights. Pathology. 2012;5:23–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.

    PubMed  Google Scholar 

  23. Kim KM, Kang DW, Moon WS, Park JB, Park CK, Sohn JH, et al. Gastrointestinal stromal tumors in Koreans: It's incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci. 2005;20:977–84.

    PubMed  PubMed Central  Google Scholar 

  24. Ashraf M, Jha J, Choudhry A, Aggarwal B, Nayak B, Chakraborty J, et al. Neoadjuvant and adjuvant therapy with Imatinib for locally advanced gastrointestinal stromal tumors in eastern Indian patients. Asian Pacific J Cancer Res. 2011;11:2059–64.

    Google Scholar 

  25. Lamba M, Mukherjee G, Saini K. Clinicopathologic pattern of gastrointestinal stromal tumors in southern India: a single institution experience. J Clin Oncol. 2007;25:2053–61.

    Google Scholar 

  26. Caterino S, Lorenzon L, Petrucciani N, Iannicelli E, Pilozzi E, Romiti A, et al. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol. 2011;9:13. Available at http://www.wjso.com/content/9/1/13

    PubMed  PubMed Central  Google Scholar 

  27. Sözütek D, Yanık S, Akkoca AN, Sözütek A, Ozdemir ZT, Avşar CU, et al. Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced / metastatic disease. Int J Clin Exp Med. 2014;74:1914–22.

    Google Scholar 

  28. Naguib SF, Zaghloul AS, El Marakby H. Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National Cancer Institute. J Egypt Natl Canc Inst. 2008;20:80–9.

    PubMed  Google Scholar 

  29. Kim JB, Ye BD, Lee JL, Lim SB, Yu CS, Kim JC, et al. Rectal gastrointestinal stromal tumor: clinical features, endoscopic findings and prognosis. Hepato-Gastroenterology. 2014;61:70–5.

    Google Scholar 

  30. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumours: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Laurini JA, Carter JE. Gastrointestinal stromal tumours: a review of the literature. Arch Pathol Lab Med. 2010;134:134–41.

    PubMed  Google Scholar 

  32. Tryggvason G, Gislason HG, Magnusson MK, Jónasson JG. Gastrointestinal stromal tumours in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289–93.

    CAS  PubMed  Google Scholar 

  33. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumours: a consensus approach. Hum Pathol. 2002;33:459–65.

    PubMed  Google Scholar 

  34. Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumours/smooth muscle tumours (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.

    CAS  PubMed  Google Scholar 

  35. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extra-gastrointestinal (soft tissue) stromal tumours: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13:577–85.

    CAS  PubMed  Google Scholar 

  36. Wahem A, Schaefer IM, Schüler P, Cameron S, Ghadimi BM. Gastrointestinal stromal tumors. Int J Color Dis. 2012;27:689–700.

    Google Scholar 

  37. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol Mech Dis. 2008;3:557–86.

    CAS  Google Scholar 

  38. Zhao X, Yue C. Gastrointestinal stromal tumors. J Gastrointest Oncol. 2012;3:189–208.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. J Surg Oncol. 2011;104:865–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors. A study of 1840 cases. Am J Surg Pathol. 2009;33:1401–8.

    PubMed  Google Scholar 

  41. Hornick JL, Fletcher CD. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol. 2007;38:679–87.

    CAS  PubMed  Google Scholar 

  42. Wong NACS. Gastrointestinal stromal tumors – an update for histopathologists. Histopathology. 2011;59:807–21.

    PubMed  Google Scholar 

  43. Patil DT, Rubin BP. Gastrointestinal stromal tumor - advances in diagnosis and management. Arch Pathol Lab Med. 2011;135:1298–310.

    CAS  PubMed  Google Scholar 

  44. Liegl B, Hornick JL, Corless CL, Fletcher CD. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol. 2009;33:437–46.

    PubMed  Google Scholar 

  45. Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008;32:210–8.

    PubMed  Google Scholar 

  46. Wong NA, Shelley-Fraser G. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology. 2010;57:250–8.

    PubMed  Google Scholar 

  47. Lopes LF, West RB, Bacchi LM, van de Rijn M, Bacchi CE. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol. 2010;18:333–7.

    PubMed  Google Scholar 

  48. Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumors. Histopathology. 2010;57:259–70.

    PubMed  Google Scholar 

  49. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30:477–89.

    PubMed  Google Scholar 

  50. Turner MS, Goldsmith JD. Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract. Arch Pathol Lab Med. 2009;133:1370–4.

    PubMed  Google Scholar 

  51. Rossi G, Valli R, Bertolini F, Marchioni A, Cavazza A, Mucciarini C, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumors and other primary soft-tissue tumors of the gastrointestinal tract. Histopathology. 2005;46:522–31.

    CAS  PubMed  Google Scholar 

  52. Lee HE, Kim MA, Lee HS, Lee BL, Kim WH. Characteristics of KIT-negative gastrointestinal stromal tumors and diagnostic utility of protein kinase C theta immunostaining. J Clin Pathol. 2008;61:722–9.

    CAS  PubMed  Google Scholar 

  53. Parkkila S, Lasota J, Fletcher JA, Ou W, Kivelä AJ, Nuorva K, et al. Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Mod Pathol. 2010;23:743–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Demir L, Ekinci N, Erten C. KucukzeybekY, Alacacioglu A, Somali I, et al. Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors? Asian Pac J Cancer Prev. 2013;14:4751–8.

    PubMed  Google Scholar 

  55. Belev B, Brčić I, Prejac J, Golubić ZA, Vrbanec D, Božikov J, et al. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. World J Gastroenterol. 2013;19:523–7.

    PubMed  PubMed Central  Google Scholar 

  56. Yang H, Shen C, Zhang B, Chen H, Chen Z, Chen J. Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor. J Korean Med Sci. 2013;28:1443–8.

    PubMed  PubMed Central  Google Scholar 

  57. Abraham SC. Distinguishing gastrointestinal stromal tumors from their mimics: an update. Adv Anat Pathol. 2007;14:178–88.

    PubMed  Google Scholar 

  58. Rink L, Godwin AK. Clinical and molecular characteristics of gastrointestinal stromal tumor in the paediatric and young adult population. Curr Oncol Rep. 2009;11:314.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, et al. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer. 2008;122:711–8.

    CAS  PubMed  Google Scholar 

  60. Agarwal R, Robson M. Inherited predisposition to gastrointestinal stromal tumour. Hematol/Oncol Clin North Am. 2009;23:1–13.

    Google Scholar 

  61. Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet. 2002;108:132–9.

    PubMed  Google Scholar 

  62. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumors and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney–Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266:43–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30:90–6.

    PubMed  Google Scholar 

  64. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, et al. Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet. 2008;16:79–88.

    CAS  PubMed  Google Scholar 

  65. Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol. 2005;29:1170–6.

    PubMed  Google Scholar 

  66. Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, et al. Gastrointestinal stromal tumours of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol. 2005;29:755–63.

    PubMed  Google Scholar 

  67. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.

    PubMed  Google Scholar 

  68. Zhang L, Smyrk TC, Young WF, Stratakis CA, Carney JA. Gastric stromal tumours in carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumours: findings in 104 cases. Am J Surg Pathol. 2010;34:53–64.

    PubMed  PubMed Central  Google Scholar 

  69. Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, et al. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol. 2008;26:626–32.

    CAS  PubMed  Google Scholar 

  70. Agaimy A. Gastrointestinal stromal tumours (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. Int J Clin Exp Pathol. 2010;3:461–71.

    PubMed  PubMed Central  Google Scholar 

  71. Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumour. Ann Surg Oncol. 2007;14:2018–27.

    PubMed  Google Scholar 

  72. Miettinen M, Fletcher CDM, Kindblom LG. WHO classification of tumors of the digestive system: mesenchymal tumor of the stomach Bosman FT World Health Organization classification of tumors. Lyon: International Agency for Research on Cancer; 2010. p. 74–9.

    Google Scholar 

  73. DeMatteo RP, Maki RG, Agulnik M, Brookland RK, Hornick JL, Jones RL, et al. Gastrointestinal stromal tumor. In: Amin MB, editor. AJCC, cancer staging manual. 8th ed. Chicago: Springer; 2017. p. 523–9.

    Google Scholar 

  74. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708–10.

    CAS  PubMed  Google Scholar 

  75. Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol. 2005;23:5357–64.

    CAS  PubMed  Google Scholar 

  76. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of C-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999;12:53–60.

    Google Scholar 

  77. Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, et al. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Mod Pathol. 2004;17:889–94.

    CAS  PubMed  Google Scholar 

  78. Niinuma T, Suzuki H, Sugai T. Molecular characterization and pathogenesis of gastrointestinal stromal. Transl Gastroenterol Hepatol. 2018;9;3:2. https://doi.org/10.21037/tgh.2018.01.02. eCollection 2018

    Article  Google Scholar 

  79. Chetty R, Serra S. Molecular and morphological correlation in gastrointestinal stromal tumours (GISTs): an update and primer. J Clin Pathol. 2016;69:754–60.

    CAS  PubMed  Google Scholar 

  80. Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res. 2004;10:3076–81.

    CAS  PubMed  Google Scholar 

  81. Ma YY, Yu S, He XJ, Xu Y, Wu F, Xia YJ, et al. Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition. Onco Targets Ther. 2014;7:637–43.

    Google Scholar 

  82. Andersson J, Bumming P, Meis-Kindblom JM. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis. Gastroenterology. 2006;130:1573–81.

    CAS  PubMed  Google Scholar 

  83. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999;59:4297–300.

    CAS  PubMed  Google Scholar 

  84. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histopathology. 2000;15:1293–301.

    CAS  Google Scholar 

  85. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O’Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Investig. 1998;78:1633–6.

    CAS  PubMed  Google Scholar 

  86. Wardelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer HP, et al. C-kit mutations in gastrointestinal stromal tumors occur preferentially in spindle rather than in the epithelioid cell variant. Mod Pathol. 2002;15:125–36.

    PubMed  Google Scholar 

  87. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal). Jpn J Cancer Res. 1999;90:1321–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Lasota J, Kuban W, Wardelmann E, Debiec-Rychter M, Merkelbach-Bruse S, Sciot R, et al. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants. Hum Pathol. 2008;39:1728–36.

    CAS  PubMed  Google Scholar 

  89. Baker G, Babb C, Schnugh D, Nayler S, Louw M, Goedhals J, et al. Molecular characterisation of gastrointestinal stromal tumours in a South African population. Oncol Lett. 2013;5:155–60.

    CAS  PubMed  Google Scholar 

  90. Heinrich MC, Corless CL, Demetri GD, Blanke CD, Mehren MV, Joensuu H, et al. Kinase mutations and Imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21:4342–9.

    CAS  PubMed  Google Scholar 

  91. Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer. 2001;92:657–62.

    CAS  PubMed  Google Scholar 

  92. Maleddu A, Pantaleo MA, Nannini M, Biasco G. The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. J Transl Med. 2011;9:75. Available on: http://www.translational-medicine.com/content/9/1/75.

  93. Tzen CY, Wang MN, Ma BL. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors. Eur J Surg Oncol. 2008;34:563–8.

    CAS  PubMed  Google Scholar 

  94. Daum O, Grossmann P, Vanecek T, Sima R, Mukensnabl P, Michal M. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Ann Diagn Pathol. 2007;11:27–33.

    PubMed  Google Scholar 

  95. Belinsky MG, Cai KQ, Zhou Y, Luo B, Pei J, Rink L, et al. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST. BMC Cancer. 2017;17:512.

    PubMed  PubMed Central  Google Scholar 

  96. Ibrahim A, Chopra S. Succinate dehydrogenase-deficient gastrointestinal stromal tumors. Arch Pathol Lab Med. 2020;144:655–60. https://doi.org/10.5858/arpa.2018-0370-RS.

    Article  CAS  PubMed  Google Scholar 

  97. Miettinen M, Lasota J. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs)—a review. Int J Biochem Cell Biol. 2014;53:514–9.

    CAS  PubMed  Google Scholar 

  98. Liu W. Clinicopathologic study of succinate dehydrogenase-deficient gastrointestinal stromal tumors: a single-institutional experience in China. Medicine (Baltimore). 2017;96:e7668.

    Google Scholar 

  99. Belinsky MG, Rink L, Mehren M. Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors. Front Oncol. 2013;3:1–14.

    Google Scholar 

  100. Huss S, Pasternack H, Ihle MA, Merkelbach-Bruse S, Heitkötter B, Hartmann W, et al. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Hum Pathol. 2017;62:206–14.

    CAS  PubMed  Google Scholar 

  101. Antonescu CR. The GIST paradigm: lessons for other kinase driven cancers. J Pathol. 2011;223:251–61.

    CAS  PubMed  Google Scholar 

  102. Lee EJ, Kang G, Kang SW, Jang KT, Lee J, Park JO, et al. GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumors. PLoS One. 2013;8:e77219.

    Google Scholar 

  103. Agaram NP, Besmer P, Wong GC, Guo T, Socci ND, Maki RG, et al. Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors. Clin Cancer Res. 2007;13:170–81.

    CAS  PubMed  Google Scholar 

  104. Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol. 2006;24:4764–74.

    CAS  PubMed  Google Scholar 

  105. Priya V, Kumari N, Krishnani N. Morphological correlates of KIT and PDGFRA genotypes in gastrointestinal stromal tumour. Turk Patoloji Derg. 2020;36:116–25.

    CAS  PubMed  Google Scholar 

  106. Priya V, Kumari N, Krishnani N. Extraintestinal gastrointestinal stromal tumor: is it biologically different from gastrointestinal stromal tumor. Gastrointest Cancer Res Ther. 2017;2:1015.

    Google Scholar 

  107. Li GZ, Raut CP. Targeted therapy and personalized medicine in gastrointestinal stromal stumors: drug resistance, mechanisms, and treatment strategies. Onco Targets Ther. 2019;12:5123–33.

    Google Scholar 

  108. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol. 2001;14:950–6.

    CAS  PubMed  Google Scholar 

  109. Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol. 1988;19:257–64.

    CAS  PubMed  Google Scholar 

  110. Kwon MS, Lee SS, Ahn GH. Schwannomas of the gastrointestinal tract: clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract. 2002;198:605–13.

    PubMed  Google Scholar 

  111. Voltaggio L, Murray R, Lasota J, Miettinen M. Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature. Hum Pathol. 2012;43:650–9.

    CAS  PubMed  Google Scholar 

  112. Rubin BP, Hornick JL. Mesenchymal tumors of the gastrointestinal tract. In: Hornick JL, editor. Practical soft tissue pathology a diagnostic approach. 2nd ed. Philadelphia: Elsevier; 2019. p. 459–98.

    Google Scholar 

  113. Liegl B, Bennett MW, Fletcher CD. Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations. Am J Surg Pathol. 2008;32:1080–7.

    PubMed  Google Scholar 

  114. Buetow PC, Levine MS, Buck JL, Pantongrag-Brown L, Emory TS. Duodenal gangliocytic paraganglioma: CT, MR imaging, and US findings. Radiology. 1997;204:745–7.

    CAS  PubMed  Google Scholar 

  115. Weinrach DM, Wang KL, Blum MG, Yeldandi AV, Laskin WB. Multifocal presentation of gangliocytic paraganglioma in the mediastinum and esophagus. Hum Pathol. 2004;35:1288–91.

    PubMed  Google Scholar 

  116. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol. 1989;92:1–9.

    CAS  PubMed  Google Scholar 

  117. van Eeden S, Offerhaus GJ, Peterse HL, Dingemans KP, Blaauwgeers HL. Gangliocytic paraganglioma of the appendix. Histopathology. 2000;36:47–9.

    PubMed  Google Scholar 

  118. Cheithauer BW, Nora FE, Le Chago J, Wick MR, Crawford BG, Weiland LH, et al. Duodenal gangliocytic paraganglioma: clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol. 1986;86:559–65.

    Google Scholar 

  119. Rowsell C, Coburn N, Chetty R. Gangliocytic paraganglioma: a rare case with metastases of all 3 elements to liver and lymph nodes. Ann Diagn Pathol. 2011;15:467–71.

    PubMed  Google Scholar 

  120. Cathcart SJ, Sasson AR, Kozel JA, Oliveto JM, Ly QP. Duodenal gangliocytic paraganglioma with lymph node metastases: a case report and comparative review of 31 cases. World J Clin Cases. 2017;5:222–33.

    PubMed  PubMed Central  Google Scholar 

  121. Gibson JA, Hornick JL. Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol. 2009;33:781–7.

    PubMed  Google Scholar 

  122. Chan OT, Haghighi P. Hamartomatous polyps of the colon: ganglioneuromatous, stromal, and lipomatous. Arch Pathol Lab Med. 2006;130:1561–6.

    PubMed  Google Scholar 

  123. Stanich PP, Owens VL, Sweetser S, Khambatta S, Smyrk TC, Richardson RL, et al. Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc. 2011;86:489–92.

    PubMed  PubMed Central  Google Scholar 

  124. Coriat R, Mozer M, Caux F, Chryssostalis A, Terris B, Grandjouan S, et al. Endoscopic findings in Cowden syndrome. Endoscopy. 2011;43:723–6.

    CAS  PubMed  Google Scholar 

  125. Carney JA, Go VL, Sizemore GW, Hayles AB. Alimentary-tract ganglioneuromatosis: a major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med. 1976;295:1287–91.

    CAS  PubMed  Google Scholar 

  126. Thway K, Fisher C. Diffuse ganglioneuromatosis in small intestine associated with neurofibromatosis type 1. Ann Diagn Pathol. 2009;13:50–4.

    PubMed  Google Scholar 

  127. Groisman GM, Polak-Charcon S. Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity? Am J Surg Pathol. 2008;32:1088–94.

    PubMed  Google Scholar 

  128. Hornick JL, Fletcher CD. Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases. Am J Surg Pathol. 2005;29:859–65.

    PubMed  Google Scholar 

  129. Pai RK, Mojtahed A, Rouse RV, Roy M, Soetikno, Tonya Kaltenbach, Lisa Ma, et al. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am J Surg Pathol. 2011;35:1373–80.

    PubMed  Google Scholar 

  130. Rittershaus AC, Appelman HD. Benign gastrointestinal mesenchymal BUMPS: a brief review of some spindle cell polyps with published names. Arch Pathol Lab Med. 2011;135:1311–9.

    PubMed  Google Scholar 

  131. Han J, Chong Y, Kim TJ, Lee EJ, Kang CS. Mucosal schwann cell hamartoma in colorectal mucosa: a rare benign lesion that resembles gastrointestinal neuroma. J Pathol Transl Med. 2017;51:187–9.

    PubMed  Google Scholar 

  132. Johnston J, Helwig EB. Granular cell tumors of the gastrointestinal tract and perianal region: a study of 74 cases. Dig Dis Sci. 1981;26:807–16.

    CAS  PubMed  Google Scholar 

  133. An S, Jang J, Min K, Kim MS, Park H, Park YS, et al. Granular cell tumor of the gastrointestinal tract: histologic and immunohistochemical analysis of 98 cases. Hum Pathol. 2015;46:813–9.

    CAS  PubMed  Google Scholar 

  134. Singhi AD, Montgomery EA. Colorectal granular cell tumor: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2010;34:1186–92.

    PubMed  Google Scholar 

  135. Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol. 1998;22:779–94.

    CAS  PubMed  Google Scholar 

  136. Filie AC, Lage JM, Azumi N. Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors. Mod Pathol. 1996;9:888–92.

    CAS  PubMed  Google Scholar 

  137. Kurtin PJ, Bonin DM. Immunohistochemical demonstration of the lysosome-associated glycoprotein CD68 (KP-1) in granular cell tumors and schwannomas. Hum Pathol. 1994;25:1172–17.

    CAS  PubMed  Google Scholar 

  138. Schoolmeester JK, Lastra RR. Granular cell tumors overexpress TFE3 without corollary gene rearrangement. Hum Pathol. 2015;46:1242–3.

    CAS  PubMed  Google Scholar 

  139. Agaimy A, Wunsch PH. True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute. Langenbeck's Arch Surg. 2007;392:75–81.

    Google Scholar 

  140. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211–22.

    CAS  PubMed  Google Scholar 

  141. McKeeby JL, Li X, Zhuang Z, Huang S, Pirner M, Skarulis MC, et al. Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1. Am J Pathol. 2001;159:1121–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  142. Lee LS, Nance M, Kaiser LR, Kucharczuk JC. Familial massive leiomyoma with esophageal leiomyomatosis: an unusual presentation in a father and his 2 daughters. J Pediatr Surg. 2005;40:e29–32.

    PubMed  Google Scholar 

  143. Jiang W, Rice TW, Goldblum JR. Esophageal leiomyoma: experience from a single institution. Dis Esophagus. 2013;26:167–74.

    CAS  PubMed  Google Scholar 

  144. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27:625–41.

    PubMed  Google Scholar 

  145. Miettinen M, Sobin LH, Lasota J. True smooth muscle tumors of the small intestine: a clinicopathologic, immunohistochemical, and molecular genetic study of 25 cases. Am J Surg Pathol. 2009;33:430–6.

    PubMed  Google Scholar 

  146. Miettinen M, Furlong M, Sarlomo-Rikala M. A Burke, L H Sobin, J Lasota. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25:1121–33.

    CAS  PubMed  Google Scholar 

  147. Hashimoto H, Tsuneyoshi M, Enjoji M. Malignant smooth muscle tumors of the retroperitoneum and mesentery: a clinicopathologic analysis of 44 cases. J Surg Oncol. 1985;28:177–86.

    CAS  PubMed  Google Scholar 

  148. Rajani B, Smith TA, Reith JD, Goldblum JR. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases. Mod Pathol. 1999;12:21–8.

    CAS  PubMed  Google Scholar 

  149. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, et al. Desmoid tumours in familial adenomatous polyposis. Gut. 1993;35:377–81.

    Google Scholar 

  150. Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, López-Terrada D. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. Pediatr Dev Pathol. 2012;15:361–7.

    CAS  PubMed  Google Scholar 

  151. Lucas DR, al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW, Mott MJ. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003;119:339–45.

    PubMed  Google Scholar 

  152. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005;29:653–9.

    PubMed  Google Scholar 

  153. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51:509–14.

    CAS  PubMed  Google Scholar 

  154. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  155. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol. 2007;31:1299–309.

    PubMed  Google Scholar 

  156. Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, et al. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer. 2010;49:560–8.

    CAS  PubMed  Google Scholar 

  157. Lazar AJ, Hajibashi S, Lev D. Desmoid tumor: from surgical extirpation to molecular dissection. Curr Opin Oncol. 2009;21:352–9.

    CAS  PubMed  Google Scholar 

  158. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.

    CAS  PubMed  Google Scholar 

  159. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428–37.

    CAS  PubMed  Google Scholar 

  160. Makhlouf HR, Sobin LH. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps? Hum Pathol. 2002;33:307–15.

    PubMed  Google Scholar 

  161. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35:135–44.

    PubMed  Google Scholar 

  162. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum: a tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15:1146–56.

    CAS  PubMed  Google Scholar 

  163. Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol. 1998;11:364–8.

    CAS  PubMed  Google Scholar 

  164. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569–76.

    CAS  PubMed  Google Scholar 

  165. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159:411–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  166. Griffin CA, Hawkins AL, Dvorak C. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 1999;59:2776–80.

    CAS  PubMed  Google Scholar 

  167. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer. 2003;37:98–105.

    CAS  PubMed  Google Scholar 

  168. Lee JC, Li CF, Huang HY, Zhu MJ, Mariño-Enríquez A, Lee CT, et al. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. J Pathol. 2017;241:316–23.

    CAS  PubMed  Google Scholar 

  169. Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Mod Pathol. 2015;28:732–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  170. Lasota J, Wang ZF, Sobin LH, Miettinen M. Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. Mod Pathol. 2009;22:1049–56.

    CAS  PubMed  Google Scholar 

  171. Schildhaus HU, Cavlar T, Binot E, Büttner R, Wardelmann E, Merkelbach-Bruse S. Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol. 2008;216:176–82.

    CAS  PubMed  Google Scholar 

  172. Kolodziejczyk P, Yao T, Tsuneyoshi M. Inflammatory fibroid polyp of the stomach. A special reference to an immunohistochemical profile of 42 cases. Am J Surg Pathol. 1993;17:1159–68.

    CAS  PubMed  Google Scholar 

  173. Ozolek JA, Sasatomi E, Swalsky PA, Rao U, Krasinskas A, Finkelstein SD. Inflammatory fibroid polyps of the gastrointestinal tract: clinical, pathologic, and molecular characteristics. Appl Immunohistochem Mol Morphol. 2004;12:59–66.

    PubMed  Google Scholar 

  174. Allibone RO, Nanson JK, Anthony PP. Multiple and recurrent inflammatory fibroid polyps in a Devon family (‘Devon polyposis syndrome’): an update. Gut. 1992;33:1004–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  175. Hasegawa T, Yang P, Kagawa N, Hirose T, Sano T. CD34 expression by inflammatory fibroid polyps of the stomach. Mod Pathol. 1997;10:451–6.

    CAS  PubMed  Google Scholar 

  176. Ricci R, Martini M, Cenci T, Carbone A, Lanza P, Biondi A. PDGFRA-mutant syndrome. Mod Pathol. 2015;28:954–64.

    CAS  PubMed  Google Scholar 

  177. Miettinen M, Makhlouf HR, Sobin LH, Lasota J. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol. 2009;33:1624–32.

    PubMed  Google Scholar 

  178. Takahashi Y, Shimizu S, Ishida T, Aita K, Toida S, Fukusato T, et al. Plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol. 2007;31:724–8.

    PubMed  Google Scholar 

  179. Yoshida A, Klimstra DS, Antonescu CR. Plexiform angiomyxoid tumor of the stomach. Am J Surg Pathol. 2008;32:1910–2.

    PubMed  Google Scholar 

  180. Spans L, Fletcher CD, Antonescu CR, Rouquette A, Coindre JM, Sciot R, et al. Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol. 2016;239:335–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  181. Galant C, Rousseau E, Ho Minh Duc DK, Pauwels P. Re: plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol. 2008;32:1910.

    PubMed  Google Scholar 

  182. Rau TT. Hartmann A, Dietmaier W, J Schmitz, W Hohenberger, F Hofstaedter, et al. Plexiform angiomyxoid myofibroblastic tumour: differential diagnosis of gastrointestinal stromal tumour in the stomach. J Clin Pathol. 2008;61:1136–7.

    CAS  PubMed  Google Scholar 

  183. Takahashi Y, Suzuki M, Fukusato T. Plexiform angiomyxoid myofibroblastic tumor of the stomach. World J Gastroenterol. 2010;16:2835–40.

    PubMed  PubMed Central  Google Scholar 

  184. Rubin BP, Hornick JL. Mesenchymal tumors of the gastrointestinal tract. In: Hornick JL, editor. Practical soft tissue pathology: a diagnostic approach. 2nd ed. Philadelphia: Elsevier; 2019. p. 459–98.

    Google Scholar 

  185. Lee HW, Lee JJ, Yang DH, Lee BH. A clinicopathologic study of glomus tumor of the stomach. J Clin Gastroenterol. 2006;40:717–20.

    PubMed  Google Scholar 

  186. Downs-Kelly E, Rubin BP, Goldblum JR. Mesenchymal tumors of the gastrointestinal tract. In: Odze R, Goldblum JR, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. 3rd ed. Philadelphia: Elsevier/Saunders; 2015. p. 822–45.

    Google Scholar 

  187. Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol. 2002;26:301–11.

    PubMed  Google Scholar 

  188. Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol. 1991;86:715–8.

    CAS  PubMed  Google Scholar 

  189. Friedman SL, Wright TL, Altman DF. Gastrointestinal Kaposi’s sarcoma in patients with acquired immunodeficiency syndrome: endoscopic and autopsy findings. Gastroenterology. 1985;89:102–8.

    CAS  PubMed  Google Scholar 

  190. Parente F, Cernuschi M, Orlando G, Rizzardini G, Lazzarin A, Bianchi PG. Kaposi’s sarcoma and AIDS: frequency of gastrointestinal involvement and its effect on survival. A prospective study in a heterogeneous population. Scand J Gastroenterol. 1991;26:1007–12.

    CAS  PubMed  Google Scholar 

  191. Weprin L, Zollinger R, Clausen K, Thomas FB. Kaposi’s sarcoma: endoscopic observations of gastric and colon involvement. J Clin Gastroenterol. 1982;4:357–60.

    CAS  PubMed  Google Scholar 

  192. Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol. 2004;28:298–307.

    PubMed  Google Scholar 

  193. Tascilar O, Cakmak GK, Gun BD, Uçan BH, Balbaloglu H, Cesur A, et al. Clinical evaluation of submucosal colonic lipomas: decision making. World J Gastroenterol. 2006;12:5075–7.

    PubMed  PubMed Central  Google Scholar 

  194. Bijlani RS, Kulkarni VM, Shahani RB, Shah HK, Dalvi A, Samsi AB. Gastric lipoma presenting as obstruction and hematemesis. J Postgrad Med. 1993;39:42–3.

    CAS  PubMed  Google Scholar 

  195. Fletcher CD, Akerman M, Dal Cin P, de Wever I, Mandahl N, Mertens F, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors: a report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996;148:623–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  196. Rosai J, Akerman M, Dal Cin P, DeWever I, Fletcher CD, Mandahl N, et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol. 1996;20:1182–9.

    CAS  PubMed  Google Scholar 

  197. Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21:943–9.

    CAS  PubMed  Google Scholar 

  198. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41:1–15.

    CAS  PubMed  Google Scholar 

  199. Hornick JL, Fletcher CD. PEComa: what do we know so far? Histopathology. 2006;48:75.

    CAS  PubMed  Google Scholar 

  200. Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, et al. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal “PEComatosis”: a clinicopathological study with comparative genomic hybridization analysis. World J Surg Oncol. 2004;2:35.

    PubMed  PubMed Central  Google Scholar 

  201. Ryan P, Nguyen VH, Gholoum S, Carpineta L, Abish S, Ahmed NN, et al. Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract. Am J Surg Pathol. 2009;33:475–82.

    PubMed  Google Scholar 

  202. Doyle LA, Hornick JL, Fletcher CD. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2013;37:1769–82.

    PubMed  Google Scholar 

  203. Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395–406.

    PubMed  Google Scholar 

  204. Agaram NP, Sung YS, Zhang L, Chen CL, Chen HW, Singer S, et al. Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol. 2015;39:813–25.

    PubMed  PubMed Central  Google Scholar 

  205. Pauwels P, Debiec-Rychter M, Sciot R, Vlasveld T, Butter BD, Hagemeijer A, et al. Clear cell sarcoma of the stomach. Histopathology. 2002;41:526–30.

    CAS  PubMed  Google Scholar 

  206. Huang W, Zhang X, Li D, Meng K, Wang Y, Lu Z, et al. Osteoclast-rich tumor of the gastrointestinal tract with features resembling those of clear cell sarcoma of soft parts. Virchows Arch. 2006;448:200–3.

    PubMed  Google Scholar 

  207. Zambrano E, Reyes-Mugica M, Franchi A, Rosai J. An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator. Int J Surg Pathol. 2003;11:75–81.

    PubMed  Google Scholar 

  208. Lagmay JP, Ranalli M, Arcila M, Baker P. Clear cell sarcoma of the stomach. Pediatr Blood Cancer. 2009;53:214–6.

    PubMed  Google Scholar 

  209. Donner LR, Trompler RA, Dobin S. Clear cell sarcoma of the ileum: the crucial role of cytogenetics for the diagnosis. Am J Surg Pathol. 1998;22:121–4.

    CAS  PubMed  Google Scholar 

  210. Taminelli L, Zaman K, Gengler C, Peloponissios N, Bouzourene H, Coindre LM, et al. Primary clear cell sarcoma of the ileum: an uncommon and misleading site. Virchows Arch. 2005;447:772–7.

    PubMed  Google Scholar 

  211. Antonescu CR, Nafa K, Segal NH, Cin PD, Ladanyi M. EWS-CREB1—a recurrent variant fusion in clear cell sarcoma: association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res. 2006;12:5356–62.

    CAS  PubMed  Google Scholar 

  212. Rosai J. Clear cell sarcoma and osteoclast-rich clear cell sarcoma-like tumor of the gastrointestinal tract: one tumor type or two? Melanoma or sarcoma? Editorial Int J Surg Pathol. 2005;13:309–11.

    PubMed  Google Scholar 

  213. Kosemehmetoglu K, Folpe AL. Clear cell sarcoma of tendons and aponeuroses, and osteoclast-rich tumour of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: a review and update. J Clin Pathol. 2010;63:416–23.

    PubMed  Google Scholar 

  214. Stockman DL, Miettinen M, Suster S, Spagnolo D, Malagon HD, Hornick JL, et al. Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract. Am J Surg Pathol. 2012;36:857–68.

    PubMed  PubMed Central  Google Scholar 

  215. Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA. Gastrointestinal melanoma or clear cell sarcoma? molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol. 2008;32:858–66.

    PubMed  Google Scholar 

  216. Bloch MJ, Iozzo RV, Edmunds LH Jr, Brooks JJ. Polypoid synovial sarcoma of the esophagus. Gastroenterology. 1987;92:229–33.

    CAS  PubMed  Google Scholar 

  217. Amr SS, Shihabi NK, Al HH. Synovial sarcoma of the esophagus. Am J Otolaryngol. 1984;5:266–9.

    CAS  PubMed  Google Scholar 

  218. Billings SD, Meisner LF, Cummings OW, Tejada E. Synovial sarcoma of the upper digestive tract: a report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization. Mod Pathol. 2000;13:68–76.

    CAS  PubMed  Google Scholar 

  219. Makhlouf HR, Ahrens W, Agarwal B, Dow N, Marshalleck JJ, Lee EL, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol. 2008;32:275–81.

    PubMed  Google Scholar 

  220. Anton-Pacheco J, Cano I, Cuadros J, Vilariño A, Berchi F. Synovial sarcoma of the esophagus. J Pediatr Surg. 1996;31:1703–5.

    CAS  PubMed  Google Scholar 

  221. Schreiber-Facklam H, Bode-Lesniewska B, Frigerio S, Flury R. Primary monophasic synovial sarcoma of the duodenum with SYT/SSX2 type of translocation. Hum Pathol. 2007;38:946–9.

    CAS  PubMed  Google Scholar 

  222. Hostetter RB, Yan M, Vaghefi H, Pennington K, Cornette G, et al. The first documented case of high-grade synovial cell sarcoma of the rectum. J Natl Compr Cancer Netw. 2012;10:947–50.

    Google Scholar 

  223. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62:135–40.

    Google Scholar 

  224. Wey EA, Britton AJ, Sferra JJ, Kasunic T, Pepe LR, Appelman HD. Gastroblastoma in a 28-year-old man with nodal metastasis: proof of the malignant potential. Arch Pathol Lab Med. 2012;136:961–4.

    PubMed  Google Scholar 

  225. Poizat F, de Chaisemartin C, Bories E, Delpero JR, Xerri L, Flejou JF, et al. A distinctive epitheliomesenchymal biphasic tumor in the duodenum: the first case of duodenoblastoma? Virchows Arch. 2012;461:379–83.

    CAS  PubMed  Google Scholar 

Download references

Disclaimer

The authors agree to the fact that all biopsy procedures and surgical resections were performed after taking informed consent from respective patients as per the individual Institutional policies, which also includes consent for publishing the unidentified clinical images for publication or research purposes. The authors also declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology & Lab Medicine, All India Institute of Medical Sciences, Raebareli, India

    Niraj Kumari

  2. Department of Pathology, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India

    Ravindra K. Saran & Monika Sharma

  3. Asian Institute of Gastroenterology, Hyderabad, India

    Anuradha Sekaran

Authors
  1. Niraj Kumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravindra K. Saran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anuradha Sekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monika Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  2. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Siddhartha Datta Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kumari, N., Saran, R.K., Sekaran, A., Sharma, M. (2022). Pathology of Mesenchymal Lesions of GI Tract. In: Das, P., Majumdar, K., Datta Gupta, S. (eds) Surgical Pathology of the Gastrointestinal System. Springer, Singapore. https://doi.org/10.1007/978-981-16-6395-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6395-6_20

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6394-9

  • Online ISBN: 978-981-16-6395-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation